Various therapeutic interventions, such as anti-rheumatic drugs, tumor necrosis factor (TNF)-α inhibitors, and interleukin (IL)-1 and IL-6 blockades, have been used for RA [2,3]. Here, IL6 is linked to rheumatoid arthritis.